Antipsychotics are used for short-term management of acute psychoses and agitated states, as well as long-term treatment of chronic psychotic disorders such as schizophrenia and delusional disorders.
The second-generation antipsychotics (SGAs), popularly known as "atypical antipsychotics," combine efficacy with low risk of extrapyramidal symptoms (EPS) relative to the traditional first-generation antipsychotics (haloperidol, chlorpromazine, etc.).
The atypical antipsychotics include clozapine, risperidone, paliperidone, olanzapine, quetiapine, amisulpride, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, and cariprazine.
Although atypical antipsychotics were thought to be " safer" because of low propensity for EPS, their ability to cause metabolic syndromes . . .
Please Subscribe to continue reading
